Pulmonary hypertension with 2020 vision

Affiliations

¹ Geschäftsführender Direktor, Physiologisches Institut, Justus-Liebig Universität, Gießen, Germany.
² National Heart and Lung Institute, Imperial College London, London, UK.

Free article

Editorial

Rainer Schulz et al. Br J Pharmacol. 2021 Jan.

Free article

. 2021 Jan;178(1):3-5.

doi: 10.1111/bph.15328.

¹ Geschäftsführender Direktor, Physiologisches Institut, Justus-Liebig Universität, Gießen, Germany.
² National Heart and Lung Institute, Imperial College London, London, UK.

No abstract available

References

1. Boengler, K., Schlüter, K. D., Schermuly, R. T., & Schulz, R. (2020). Cardioprotection in right heart failure. British Journal Pharmacology, 177(23), 5413-5431. https://doi.org/10.1111/bph.14992
1. Chelladurai, P., Boucherat, O., Stenmark, K., Kracht, M., Seeger, W., Bauer, U. M., … Pullamsetti, S. S. (2020). Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy. British Journal Pharmacology, 178(1), 54-71. https://doi.org/10.1111/bph.14932
1. Fu, C., Lu, Y., Williams, M. A., Brantly, M. L., Ventetuolo, C. E., Morel, L. M., … Bryant, A. J. (2020). Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling. British Journal Pharmacology, 178(1), 187-202. https://doi.org/10.1111/bph.14945
1. Fysikopoulos, A., Seimetz, M., Hadzic, S., Knoepp, Wu, C. Y., Malkmus, K., … Kraut, S. (2020). Amelioration of elastase-induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice. British Journal Pharmacology, 178(1), 152-171. https://doi.org/10.1111/bph.15057
1. Gassmann, M., Cowburn, A., Gu, H., Li, J., Rodriguez, M., Babicheva, A., … Zhao, L. (2020). Hypoxia-induced pulmonary hypertension-utilizing experiments of nature. British Journal Pharmacology, 178(1), 121-131. https://doi.org/10.1111/bph.15144